Anthera Pharmaceuticals Inc (ANTH)
0.00
USD |
OTCM |
May 03, 16:00
Anthera Pharmaceuticals Cash from Operations (TTM): -31.95M for March 31, 2018
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
March 31, 2018 | -31.95M |
December 31, 2017 | -36.90M |
September 30, 2017 | -42.87M |
June 30, 2017 | -51.33M |
March 31, 2017 | -52.54M |
December 31, 2016 | -48.92M |
September 30, 2016 | -46.14M |
June 30, 2016 | -40.19M |
March 31, 2016 | -35.00M |
December 31, 2015 | -30.91M |
September 30, 2015 | -27.69M |
June 30, 2015 | -25.17M |
March 31, 2015 | -26.94M |
December 31, 2014 | -25.60M |
September 30, 2014 | -25.06M |
June 30, 2014 | -25.30M |
March 31, 2014 | -26.55M |
Date | Value |
---|---|
December 31, 2013 | -31.91M |
September 30, 2013 | -41.70M |
June 30, 2013 | -49.04M |
March 31, 2013 | -60.99M |
December 31, 2012 | -73.64M |
September 30, 2012 | -84.12M |
June 30, 2012 | -88.70M |
March 31, 2012 | -86.50M |
December 31, 2011 | -73.07M |
September 30, 2011 | -56.30M |
June 30, 2011 | -45.39M |
March 31, 2011 | -34.13M |
December 31, 2010 | -27.78M |
September 30, 2010 | -25.43M |
June 30, 2010 | -21.72M |
March 31, 2010 | -16.98M |
December 31, 2009 | -17.17M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
NovaBay Pharmaceuticals Inc | -4.131M |
Palatin Technologies Inc | -26.54M |
iBio Inc | -18.89M |
Theriva Biologics Inc | -19.00M |
Oragenics Inc | -7.291M |